M. J. Hayton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. J. Hayton has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
J.K. Stanley
Wrightington Hospital, Hall Lane, Appley Bridge, Wigan WN6 9EP, United Kingdom. address for M.J. Hayton
2 shared publicationsA. J.A. Santini
1 shared publicationA.J.A. Santini
Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, United Kingdom
1 shared publicationI. A. Trail
1 shared publicationI.A. Trail
Wrightington Hospital, Hall Lane, Appley Bridge, Wigan WN6 9EP, United Kingdom. address for M.J. Hayton
1 shared publicationI.C.M. Gray
The Royal Liverpool University Hospital, Liverpool, UK
1 shared publication
Latest Publications
- Open Access
- 17 January 2013
- Published by Springer Nature
Trapezium implant versus sling procedure in the treatment of thumb carpometacarpal arthritis: A randomised, assessor blinded controlled trial
- 17 January 2013
- Published by Springer Nature
Open AccessTrapezium implant versus sling procedure in the treatment of thumb carpometacarpal arthritis: A randomised, assessor blinded controlled trial
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (3) , 503-507
BOTULINUM TOXIN INJECTION IN THE TREATMENT OF TENNIS ELBOW
His theory, we performed a double-blind, randomized, controlled, pilot trial comparing injections of botulinum toxin type A with those of a placebo (normal saline solution) in the treatment of chronic tennis elbow....
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (3) , 503-507
BOTULINUM TOXIN INJECTION IN THE TREATMENT OF TENNIS ELBOW
His theory, we performed a double-blind, randomized, controlled, pilot trial comparing injections of botulinum toxin type A with those of a placebo (normal saline solution) in the treatment of chronic tennis elbow....
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (3) , 503-507
Botulinum Toxin Injection in the Treatment of Tennis Elbow
Background: A recent report has suggested that local injection of botulinum toxin type A is an effective method of treatment for chronic tennis elbow. The toxin is thought to provide temporary paralysis of the painful common extensor origin, thereby allowing a healing response to occur. To test this theory, we performed a double-blind, randomized, controlled, pilot trial comparing injections of botulinum toxin type A with those of a placebo (normal saline solution) in the treatment of chronic tennis elbow. Methods: Forty patients with a history of chronic tennis elbow for which all conservative treatment measures, including steroid injection, had failed were randomized into two groups. Half the patients received 50 units of botulinum toxin type A, and the remainder received normal saline solution. The intramuscular injections were performed 5 cm distal to the maximum point of tenderness at the lateral epicondyle, in line with the middle of the wrist. The two solutions used for the injections were identical in appearance and temperature. The results of a quality-of-life assessment with the Short Form-12 (SF-12), the pain score on a visual analogue scale, and the grip strength measured with a validated Jamar dynamometer were recorded before and three months after the injection. Results: Three months following the injections, there was no significant difference between the two groups with regard to grip strength, pain, or quality of life. Conclusions: With the numbers studied, we failed to find a significant difference between the two groups; thus, we have no evidence of a benefit from botulinum toxin injection in the treatment of chronic tennis elbow. Level of Evidence: Therapeutic Level II. See Instructions to Authors for a complete description of levels of evidence.
- 1 March 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (3) , 503-507
Botulinum Toxin Injection in the Treatment of Tennis Elbow
Background: A recent report has suggested that local injection of botulinum toxin type A is an effective method of treatment for chronic tennis elbow. The toxin is thought to provide temporary paralysis of the painful common extensor origin, thereby allowing a healing response to occur. To test this theory, we performed a double-blind, randomized, controlled, pilot trial comparing injections of botulinum toxin type A with those of a placebo (normal saline solution) in the treatment of chronic tennis elbow. Methods: Forty patients with a history of chronic tennis elbow for which all conservative treatment measures, including steroid injection, had failed were randomized into two groups. Half the patients received 50 units of botulinum toxin type A, and the remainder received normal saline solution. The intramuscular injections were performed 5 cm distal to the maximum point of tenderness at the lateral epicondyle, in line with the middle of the wrist. The two solutions used for the injections were identical in appearance and temperature. The results of a quality-of-life assessment with the Short Form-12 (SF-12), the pain score on a visual analogue scale, and the grip strength measured with a validated Jamar dynamometer were recorded before and three months after the injection. Results: Three months following the injections, there was no significant difference between the two groups with regard to grip strength, pain, or quality of life. Conclusions: With the numbers studied, we failed to find a significant difference between the two groups; thus, we have no evidence of a benefit from botulinum toxin injection in the treatment of chronic tennis elbow. Level of Evidence: Therapeutic Level II. See Instructions to Authors for a complete description of levels of evidence.
- 1 September 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (3) , 447-451
A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis
Injection of botulinum toxin type A (BTX‐A) is an effective method of controlling palmar hyperhidrosis. It is, however, an uncomfortable procedure without adequate anaesthesia. We outline the techniq...
- 1 September 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (3) , 447-451
A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis
Injection of botulinum toxin type A (BTX‐A) is an effective method of controlling palmar hyperhidrosis. It is, however, an uncomfortable procedure without adequate anaesthesia. We outline the techniq...
- 28 February 2003
- Published by Elsevier in Current Orthopaedics
- Vol. 17 (1) , 1-7
(i) Dupuytren's contracture: a review
- 28 February 2003
- Published by Elsevier in Current Orthopaedics
- Vol. 17 (1) , 1-7
(i) Dupuytren's contracture: a review